BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19294418)

  • 1. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
    Zhou XD; Tang ZY; Fan J; Zhou J; Wu ZQ; Qin LX; Ma ZC; Sun HC; Qiu SJ; Yu Y; Ren N; Ye QH; Wang L; Ye SL
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):1073-80. PubMed ID: 19294418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
    Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
    Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Jung DH; Hwang S; Kim KH; Hong SM; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu ES; Lee SG
    World J Surg; 2017 Mar; 41(3):825-834. PubMed ID: 27812807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K
    J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature.
    Qu MM; Zhu YH; Li YX; Li ZF; Li JK; Xu YS; Shrestha M; Lei JQ
    Medicine (Baltimore); 2021 Nov; 100(46):e27349. PubMed ID: 34797273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
    Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776
    [No Abstract]   [Full Text] [Related]  

  • 13. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group.
    Uenishi T; Nagano H; Marubashi S; Hayashi M; Hirokawa F; Kaibori M; Matsui K; Kubo S
    J Surg Oncol; 2014 Aug; 110(2):176-81. PubMed ID: 24760391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection.
    Song P; Midorikawa Y; Nakayama H; Higaki T; Moriguchi M; Aramaki O; Yamazaki S; Aoki M; Teramoto K; Takayama T
    Cancer Med; 2019 Oct; 8(13):5862-5871. PubMed ID: 31407490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
    Tang D; Nagano H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
    J Gastrointest Surg; 2006; 10(7):987-98. PubMed ID: 16843869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis.
    Spolverato G; Bagante F; Tsilimigras D; Ejaz A; Cloyd J; Pawlik TM
    J Surg Oncol; 2019 Mar; 119(3):278-287. PubMed ID: 30554420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
    Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
    J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
    Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis.
    Sotiropoulos GC; Bockhorn M; Sgourakis G; Brokalaki EI; Molmenti EP; Neuhäuser M; Radtke A; Wohlschlaeger J; Baba HA; Broelsch CE; Lang H
    Dig Dis Sci; 2009 Apr; 54(4):887-94. PubMed ID: 18712480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.
    Jarnagin WR; Weber S; Tickoo SK; Koea JB; Obiekwe S; Fong Y; DeMatteo RP; Blumgart LH; Klimstra D
    Cancer; 2002 Apr; 94(7):2040-6. PubMed ID: 11932907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.